CANTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
CANTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
On track to submit ReNu BLA by the end of 2025Enrollment in second Phase 3 complete; significantly ahead of...
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- ย Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
CANTON, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
Statistically significant (p=0.0177) reduction in knee pain at six monthsStatistically significant...
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.